300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Biotechnology
Automotive
eSports
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Fashion
Infrastructure
Social
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
New Zealand
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in South Korea (November 2026)

The most active venture capital funds and angel investors investing in South Korea Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in South Korea Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Korea Investment Partners
VC Fund
4 South Korea, United States, China Series A, Series B, Seed Biotechnology, Health Care, Information Technology $973k–$50M
Korea Technology Finance
VC Fund
4 South Korea, Russian Federation Seed, Series A, Series B Manufacturing, Software, Health Care $383k–$15M
HB Investment
VC Fund
3 South Korea, United States, Vietnam Venture - Series Unknown, Series B, Series A Biotechnology, Software, Health Care $717k–$25M
Industrial Bank of Korea
VC Fund
3 South Korea, United States, China Series A, Series B, Seed Artificial Intelligence, Information Technology, Software $166k–$28M
Series Ventures
VC Fund
3 South Korea, Singapore Seed, Series A, Venture - Series Unknown Health Care, Manufacturing, Biotechnology $86k–$4.4M
Mirae Asset Venture Investment
VC Fund
3 South Korea, United States, India Series A, Series B, Seed Software, Artificial Intelligence, Biotechnology $692k–$52M
Kakao Ventures
VC Fund
3 South Korea, United States, Indonesia Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $266k–$27M
Premier Partners
VC Fund
2 South Korea, United States, Russian Federation Venture - Series Unknown, Series B, Series A Health Care, Biotechnology, Medical $2.6M–$154M
Quantum Ventures Korea
VC Fund
2 South Korea, United States Series A, Series B, Seed Artificial Intelligence, Software, Medical $1M–$30M
STIC Ventures
VC Fund
2 South Korea, United States, Vietnam Venture - Series Unknown, Series A, Series B Biotechnology, Software, Information Technology $2M–$47M
Technology Guarantee Fund
VC Fund
2 South Korea, Russian Federation Seed, Series A, Series B Health Care, Biotechnology, Manufacturing $415k–$10M
Boditech Med
VC Fund
2 South Korea Seed, Series A Life Science, Biotechnology, Medical $271k–$1.7M
Ulmus Investment
VC Fund
2 South Korea, United Kingdom Series B, Series A, Series C Biotechnology, Artificial Intelligence, Manufacturing $4.2M–$63M
Yozma Group
VC Fund
2 Israel, United States, South Korea Series B, Seed Software, Health Care, Medical $400k–$59M
UTC Investment Co.
VC Fund
2 South Korea, United States, Japan Series A, Venture - Series Unknown, Series B Biotechnology, Health Care, Medical $500k–$21M
Yuhan Corporation
VC Fund
2 South Korea Series B, Series C, Corporate Round Health Care, Biotechnology, Medical $2k–$40B
Timepolio Asset Management
VC Fund
2 South Korea, United States, Russian Federation Series B, Series A, Series C Biotechnology, Health Care, Manufacturing $3.4M–$80M
The Wells Investment
VC Fund
2 South Korea, United States, Singapore Series A, Series B, Seed Artificial Intelligence, Apps, Health Care $289k–$16M
Ost Investment
VC Fund
2 South Korea Series A, Seed Biotechnology, Health Care, Life Science $1.3M–$2.7M
Kingo Investment Partners
VC Fund
2 South Korea Series A, Series C, Series B Health Care, Biotechnology, Therapeutics $834k–$45M
Aju IB Investment
VC Fund
2 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Therapeutics
BSK Investment
VC Fund
2 South Korea Series A, Series B, Series C Biotechnology, Software, Health Care $2.1M–$57M
Devsisters Ventures
VC Fund
2 South Korea, United States, Russian Federation Venture - Series Unknown, Series A, Seed Software, Biotechnology, Gaming $441k–$11M
Medytox Venture Investment
VC Fund
2 South Korea Series A, Series B, Seed Biotechnology, Pharmaceutical, Medical $4k–$44M
Coolidge Corner Investment
VC Fund
2 South Korea, United States, Belgium Seed, Series A, Series B Software, Health Care, Manufacturing $260k–$14M
Daekyo Investment
VC Fund
2 South Korea, United States, Hong Kong Series A, Seed, Series B Software, Mobile Apps, Education $589k–$17M
HG Initiative
VC Fund
2 South Korea, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $360k–$13M
SJ Investment Partners
VC Fund
2 South Korea, United States, Hong Kong Series A, Series B, Seed Biotechnology, Manufacturing, Medical $547k–$27M
Clarevoyant Ventures
VC Fund
2 South Korea Seed, Series A, Series B Medical, Health Care, Life Science
DSC Investment
VC Fund
2 South Korea, United States, Israel Series A, Series B, Seed Artificial Intelligence, Health Care, Software $441k–$60M
Neoflux
VC Fund
1 South Korea, United States Series B, Series A, Seed Apps, Software, Medical $1.9M–$56M
Company K Partners
VC Fund
1 South Korea, United States, Gibraltar Series A, Series B Biotechnology, Health Care, Artificial Intelligence
JNPMEDI Partners
VC Fund
1 South Korea Seed Health Care, Life Science, Biotechnology
Yuanta Investment
VC Fund
1 South Korea, Taiwan, Vietnam Series B, Series C, Series A Financial Services, Information Technology, E-Commerce
Mirae Asset Capital
VC Fund
1 South Korea, United States, India Series B, Series A, Seed Health Care, Biotechnology, Artificial Intelligence $817k–$105M
Stick Ventures
VC Fund
1 South Korea Series B, Series A Biotechnology, Information Technology, Pharmaceutical
Kolon Investment
VC Fund
1 South Korea, Indonesia, United States Series A, Series B Biotechnology, Software, Pharmaceutical
G.N. Tech Venture
VC Fund
1 South Korea, United States Series B, Series A, Series C Biotechnology, Pharmaceutical, Health Care
KB Securities
VC Fund
1 South Korea, United States, China Series B, Series A, Venture - Series Unknown Software, Artificial Intelligence, Information Technology $1.5M–$35M
QUAD Investment Management
VC Fund
1 South Korea, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Medical $847k–$80M
Meritz Securities
VC Fund
1 South Korea, China Series C, Series A, Series B Medical, Biotechnology, Pharmaceutical $4.7M–$45M
Future Science and Technology Holdings
VC Fund
1 South Korea, United States Seed, Series A Biotechnology, Health Care, Information Technology $231k–$6.7M
Stonebridge Ventures
VC Fund
1 South Korea, United States, Japan Series A, Series B, Seed Artificial Intelligence, Biotechnology, Software $1M–$17M
Cytogen
VC Fund
1 South Korea Series A, Series C Biotechnology, Pharmaceutical, Medical
Time Folio Asset Management
VC Fund
1 South Korea, United States Series B, Series C, Series A Biotechnology, Pharmaceutical, Health Care $5M–$33M
P&I Investment
VC Fund
1 South Korea Series A, Seed Media and Entertainment, TV, Music $8.4M–$36M
Kiwoom Investment
VC Fund
1 South Korea, United States, Japan Series B, Series A, Series C Information Technology, Software, Artificial Intelligence $1.7M–$33M
Nice Investment Partners
VC Fund
1 South Korea, Japan Series A, Series B, Seed Health Care, Information Technology, Software $437k–$26M
Widwin Investment
VC Fund
1 South Korea, United States Series B, Series C, Series A Biotechnology, Medical, Health Care $584k–$47M
IBK Capital
VC Fund
1 South Korea, United States, India Series A, Seed, Series B Health Care, Biotechnology, Information Technology $148k–$17M
Access all 171 investors in South Korea Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Korea Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 4 investments in South Korea Life Science startups

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YG Entertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 548
  • Round size: Seed $973k–$10M; Series A $2.2M–$19M; Series B $4.9M–$50M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $60M in 2023

Portfolio highlights

  • Zamface — Zamface is an app that makes beauty video.
  • Wakebunny — Wakebunny is a company that specializes in IP-based commerce, leveraging intellectual property to create, market, and monetize unique products and experiences. By focusing on the strategic use of copyrights, trademarks, and brand assets, Wakebunny transforms original ideas, characters, and stories into commercially viable offerings across variousplatforms such as e-commerce, digital media, merchandising, and licensing.
  • Inovio Pharmaceuticals — INOVIO is advancing novel immunotherapy technologies to reshape the future of treating and preventing infectious diseases and cancer.
Show all investments...

Korea Technology Finance
VC Fund · Busan, Pusan-jikhalsi, South Korea · 4 investments in South Korea Life Science startups, 9 in the past 12 months

Korea Technology Finance is a government-affiliated financial institution that supports technology-based startups and small and medium-sized enterprises (SMEs). Its services include technology appraisal, credit guarantees, equity investments, intellectual property protection, and technology transfer. Korea Technology Finance helps businesses access financing based on their technological capabilities and supports the commercialization of innovative technologies.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Russian Federation

Investor stats

  • Total investments: 94
  • Round size: Seed $383k–$4.1M; Series A $1.8M–$8.4M; Series B $1.2M–$15M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • K-Bio Gateway — K-Bio Gateway is a green bio healthcare startup specializing in the research and development of room temperature stable, anti obesity probiotics and functional microbiome materials. The company utilizes its proprietary DH24 functional probiotic strain to deliver weight-management solutions, serving both B2B functional material markets and B2C consumers
  • Multiscale Instruments — Multiscale Instruments is a pioneering technology company focused on advancing precision metrology tools for the semiconductor industry. The company is currently developing a state-of-the-art atomic force microscope (AFM) specifically designed for inline semiconductor process monitoring.
  • Unmanned Exploration Laboratory — Unmanned Exploration Laboratory manufactures multirotor drones, fixed-wing aircraft, and unmanned vehicles for space exploration.
Show all investments...

HB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 3 investments in South Korea Life Science startups, 13 in the past 12 months

HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion. Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result, HB Investment Inc. constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 189
  • Round size: Series A $1.2M–$15M; Series B $3.6M–$25M; Venture - Series Unknown $717k–$23M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Trioar — Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • Yipscell — Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.
Show all investments...

Industrial Bank of Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 3 investments in South Korea Life Science startups

Industrial Bank of Korea (IBK) is committed to honoring its charter of financing small and medium sized enterprises (SMEs). The Bank has extended the scope of its expertise to provide a comprehensive range of financial services to individual customers in a quest to emerge as a leading financial services group. In pursuit of that goal, IBK is making every effort to enhance its competitiveness, achieve balanced growth and strengthen its global presence. The Bank employs around 10,000 staff and operates a distribution network of 612 branches including 12 overseas branches. Providing complementary services, the Bank also operates several subsidiaries: IBK Capital Corporation, IBK-SG Asset Management, IBK System Co., Ltd., and IBK Credit Information Corporation. In 2008, IBK Investment & Securities was launched, focused on meeting the needs of SME customers for services such as IPOs and M&As. Moreover, strategic alliance with Korea Investment Holdings enhances product competitiveness and affiliation with the National Post Office promoting easy customer access to IBK banking services.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 316
  • Round size: Seed $166k–$4.5M; Series A $2.3M–$17M; Series B $4.8M–$28M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Airbility — Korean anti-drone and counter-drone company founded in 2023 by aerospace, defense and mobility engineers. Team, milestones and careers.
Show all investments...

Series Ventures
VC Fund · Changwon, Kyongsang-namdo, South Korea · 3 investments in South Korea Life Science startups

Series Ventures is an investment company for the beauty care, engineering, healthcare, social platform, and enterprise sectors.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 98
  • Round size: Seed $86k–$1.9M; Series A $2.9M–$4.4M
  • Lead/follow: 70% lead, 30% follow

Portfolio highlights

  • ROBOS — Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical.
  • With Doctors — With Doctors growth care solution precisely evaluates and analyzes physical, nutritional, psychological, and environmental factors affecting growth to derive the child's key management factors, and design and provide safe, scientifically proven, customized growth care programs for children through collaboration between exercise, nutrition, andpsychology experts and medical staff.
  • Golden Brain Care — Golden Brain Care develops "Brain Friends," an AI-powered platform designed for speech and cognitive rehabilitation targeting patients with neurological communication disorders. The platform digitizes the speech therapy lifecycle by integrating self-assessments, tailored vocal training, real-time performance data analysis, and guardianreporting mechanisms into a single workflow. Its core value proposition focuses on extending rehabilitation from clinical environments to daily life, bypassing limitations in face-to-face medical expert capacity through personalized home care systems.
Show all investments...

Mirae Asset Venture Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 3 investments in South Korea Life Science startups

A fundamental investment philosophy of ‘Building on principles’ guides us at Mirae Asset. Over the years, these principles have enabled us to become Asia’s premier financial group and created new trends in the Asian capital market. Above all, we put our clients’ interests first, always adhering to high ethical standards. Because our success clearly comes from their success, we use fundamental investment principles to identify opportunities that generate value and lasting profits. We are strong believers in teamwork and are determined to recruit the best and brightest people as we open new horizons in Asia and expand globally. Just as we strive to continually improve our own performance, Mirae Asset is committed to helping every community it joins. On behalf of the entire Mirae Asset Financial Group, I would like to convey the sense of responsibility your trust in us merits and pledge to do all that we can to exceed your expectations.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 344
  • Round size: Seed $692k–$14M; Series A $2M–$40M; Series B $5M–$52M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely actively investing — fresh fund, raised $118M in 2026

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • NanoForge AI — Nanoforge AI merges AI-driven material design with robotics automation to cut material development time from years to weeks
  • The Pant Project — The Pant Project is an e-tailoring company that specializes in customizing pants according to individual fit and style. They offer a curated range of premium fabrics including poly viscose, knit, and wool. The company also provides a 4-way stretch technology in their formal pants for enhanced comfort and mobility. Customers can track their ordersthrough the company's website.
Show all investments...

Kakao Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 3 investments in South Korea Life Science startups

We are an independent subsidiary of Kakao Corp. & the most active, startup-friendly early stage VC of Korea. (Limited Partnerships, not strategic.).

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 430
  • Round size: Seed $266k–$4.2M; Series A $988k–$11M; Series B $3.4M–$27M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely actively investing — fresh fund, raised $40B in 2025

Portfolio highlights

  • OQT — OQT is focusing on developing QPUs utilizing neutral atoms.
  • Corologic — Korologic develops cardiovascular imaging AI solutions for medical procedures.
  • Tect Group — We deliver real beauty based on distinctive brands and innovative marketing solutions, fostering confidence and positivity around the world.
Show all investments...

Premier Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups, 13 in the past 12 months

Premier Partners (프리미어 파트너스) is a Korean domestic funds management company. It provides investment services for individuals and businesses. Premier Partners was established in September 2005 in Seoul, Korea.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 199
  • Round size: Series A $2.6M–$15M; Series B $5.8M–$45M; Venture - Series Unknown $3.3M–$154M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — raised $83M in 2023

Portfolio highlights

  • Yipscell — Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.
  • HITS — HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
  • Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Show all investments...

Quantum Ventures Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Quantum Ventures Korea actively invests in companies within the Technology and Bio/Healthcare industries. The firm manages a portfolio of early to growth-stage companies and continues to look for opportunities across a range of company stages.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States

Investor stats

  • Total investments: 80
  • Round size: Seed $1M–$7.6M; Series A $1.5M–$16M; Series B $3.6M–$30M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2019

Portfolio highlights

  • FuriosaAI — FuriosaAI develops system semiconductors optimized for AI, enabling efficient processing of large amounts of data in a short period of time.
  • S-Innovations — S-Innovations is a robotics software company that develops SynK, a cyber-physical AI operating system for robot deployment, integration, and recovery across different robot brands and industrial facilities. The company provides automation software that enables faster robot setup, system connectivity, and operational management for sectors usingautonomous mobile robots
  • READi Robust Machine — Ready Robust Machine is a company that makes carbon reduction and fuel cost improvement systems.
Show all investments...

STIC Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

STIC Ventures invests in small and mid-sized venture companies with core technologies and new business models.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 166
  • Round size: Series A $2M–$44M; Series B $8.8M–$47M; Venture - Series Unknown $3.7M–$17M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $172M in 2013

Portfolio highlights

  • Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • Pebble Square — Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Technology Guarantee Fund
VC Fund · 2 investments in South Korea Life Science startups

Technology Guarantee Fund is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Russian Federation

Investor stats

  • Total investments: 39
  • Round size: Seed $415k–$4.1M; Series A $1.4M–$7.3M; Series B $6.6M–$10M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • LYNK Solutec — LYNK Solutec is a laboratory-based company that specializes in bio-medical devices.
  • Beyond Honeycomb — Beyond Honeycomb is a food-tech company developing an AI-driven kitchen robot solution. Our AI Chef reproduces the texture and taste of the world-class chef’s dish at the molecular level.
  • DK Fine Chemical — DK Fine Chemical is committed to providing essential cellulose-based solutions that play a crucial role in various industries, including construction, paint, coatings, food, pharmaceuticals, personal care, and more. The company focuses on delivering high-quality, sustainable, and innovative cellulose compounds, tailored to meet the diverse needs ofits clients across these sectors.
Show all investments...

Boditech Med
VC Fund · Chuncheon, Kangwon-do, South Korea · 2 investments in South Korea Life Science startups

Boditech Med provides reliable In-Vitro Diagnostic Solutions for everyone at anywhere, and anytime.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: South Korea

Investor stats

  • Total investments: 4
  • Round size: Seed $271k–$1.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Raywatt — Raywatt is a medical device company developing optical coherence tomography (OCT) imaging systems used for cardiovascular diagnosis. Its technology helps doctors visualize coronary arteries in detail to support evaluation of heart conditions during medical procedures. The company focuses on improving diagnostic imaging tools for interventionalcardiology and enhancing clinical decision-making through improved vessel visualization and data accuracy.
  • RexSoft — Company provides Innovative software and services provider specializing in analytics solutions.
  • TSD Life Sciences — TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.
Show all investments...

Ulmus Investment
VC Fund · 2 investments in South Korea Life Science startups

Ulmus Investment

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Manufacturing
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Series A $4.2M–$63M; Series B $5M–$27M; Series C $8.4M–$37M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely still investing — raised $37M in 2024

Portfolio highlights

  • Dnotitia — VDPU is a PCIe card that offloads vector index building and search from your CPUs and GPUs. It works with the vector database you already run.
  • Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services. Currently, Quantum AI is providing various services centered on the financial sector, including AI document processing automation, intelligent voice consultation, assetization of unstructured financial data based on its own language model, and AIsearch. Utilizing a proprietary AI recognition engine, the company has integrated and analyzed various data sources, including financial documents, customer consultation history, and market news, and have carried out numerous AI data assetization projects for major domestic commercial banks and insurance companies.
  • Metal Link — Rio MNC is a company that has grown by focusing on steel wire for submarine cable sheathing.
Show all investments...

Yozma Group
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in South Korea Life Science startups

Yozma earned worldwide recognition as the founder of Israel's VC industry.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Series B, Seed
  • Geography: Israel, United States, South Korea

Investor stats

  • Total investments: 29
  • Round size: Seed $400k–$4.5M; Series B $2.5M–$59M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • RoomGenie — An AI-powered chatbot for hotels revolutionizes the way guests interact with in-room services by enabling seamless cross-selling and upselling. Integrated within smart devices or hotel apps, this AI solution leverages natural language processing (NLP) to communicate with guests in a conversational and personalized manner.From booking spatreatments and restaurant reservations to upgrading rooms or scheduling late checkouts, the chatbot intuitively identifies guest preferences and suggests relevant services. It analyzes data such as guest profiles, previous stays, and real-time behavior to deliver tailored recommendations, boosting both guest satisfaction and revenue.Available 24/7, the chatbot ensures instant responses to guest inquiries, reducing dependence on front-desk staff and enhancing operational efficiency. Additionally, it supports multiple languages, catering to a global clientele and making communication barrier-free. Hotels can integrate the AI chatbot with their property management systems (PMS) and point-of-sale (POS) platforms to streamline service delivery and track guest interactions.The solution empowers hotels to provide a hyper-personalized, tech-forward experience, which appeals to modern travelers. By automating cross-selling and upselling opportunities while improving guest engagement, the chatbot not only enhances the overall stay experience but also drives incremental revenue, making it a vital tool for the hospitality industry.
  • Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
  • Fine Data Lab — Fine Data Lab is a digital data analysis company offering digital marketing consulting, analytics, and data analytics solutions.
Show all investments...

UTC Investment Co.
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 131
  • Round size: Series A $2.3M–$13M; Series B $4.9M–$21M; Venture - Series Unknown $500k–$12M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Beamworks — Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
  • CanLab — CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

Yuhan Corporation
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Yuhan Co, Ltd. is a South Korean pharmaceutical and chemical company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C, Corporate Round
  • Geography: South Korea

Investor stats

  • Total investments: 17
  • Round size: Series B $13M–$40B; Series C $7.3M–$32M; Corporate Round $2k–$12M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • J INTS BIO — J INTS BIO is a biotechnology company focused on the research and development of anticancer drugs and orphan medicines. The company develops targeted therapies for conditions such as non-small cell lung cancer and solid tumors.
  • Kim Cell & Gene — Kimcell & Gene is creating antibody treatments that target resistance.
  • Nobo Medicine — Nobo Medicine is a clinical-stage biotech company focused on developing precision therapies for blood cancers and immune-related aging diseases. It uses biomarker-driven drug discovery and translational research to identify targeted treatments, aiming to improve outcomes in oncology and age-associated immune dysfunction through innovative,data-driven biomedical approaches.
Show all investments...

Timepolio Asset Management
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups, 7 in the past 12 months

Timepolio Asset Management is an asset management firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 87
  • Round size: Series A $3.4M–$17M; Series B $5.2M–$24M; Series C $10M–$80M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • HEM Pharma — HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. andsupporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships.
  • Next Securities — The Next Generation AI-driven Brokerage Services
Show all investments...

The Wells Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

VC, Venture Capital

Show more...

Investment focus

  • Industry: Artificial Intelligence, Apps, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 57
  • Round size: Seed $289k–$1.8M; Series A $1.1M–$6.1M; Series B $2.7M–$16M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Milliway — Milliway is an infrastructure digitalization startup that uses vehicle sensor data to detect and manage road damage in real time. It offers solutions for monitoring city and road events and provides tools to enhance productivity in city and road management.
  • AIT STUDIO — AIT Studio is a digital health startup that develops AI-powered, contactless gait analysis solutions for early detection of mobility decline and age-related conditions such as sarcopenia. Our flagship products—GAIT Studio (App) and MediStep M Pro (hardware package)—deliver full gait assessments in under 1 minute, without wearables or specializedstaff.
  • FLYTO — FLYTO is a South Korean aviation simulation and technology company. The company specializes in building advanced infrastructure for aviation training, aircraft maintenance education, real-flight data integration, and future Advanced Air Mobility (AAM) or Urban Air Mobility (UAM) validation.
Show all investments...

Ost Investment
VC Fund · 2 investments in South Korea Life Science startups

Ost Investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 5
  • Round size: Series A $1.3M–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pinot Bio — Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.
  • G+FLAS Life Sciences — GFLAS Life Sciences, Inc. is poised to disrupt the agricultural biotechnology sector with its pioneering advancements in CRISPR-Cas genome editing technology. Founded by Dr. Sunghwa Choe in 2014, GFLAS has swiftly established itself as a leader in biotech innovation, dedicated to enhancing human health and promoting agricultural sustainabilitythrough cutting-edge genetic engineering solutions. Our flagship innovation, the world's first vitamin D3-enriched tomatoes, addresses a critical market need by transforming the traditional tomato industry. Tomatoes are one of the most consumed vegetables globally, with the US fresh tomato market alone valued at approximately $18 billion annually, assuming an average price of $1.5 per kilogram. The consumer market value is even more substantial, estimated between $27 to $31.5 billion annually. By introducing vitamin D3-enriched tomatoes, GFLAS not only adds significant nutritional value to a staple food product but also creates a unique selling proposition that meets the increasing consumer demand for functional foods. The strategic partnership with Bayer, a global leader in agricultural science, underscores the commercial viability and substantial market potential of our technology. This collaboration has facilitated the transfer of GFLAS's vitamin D3 tomato technology to Bayer Crio Science in the USA, providing a robust pathway for large-scale commercialization and global market penetration. This partnership not only validates our technological prowess but also positions us for significant growth in the global agricultural market. Our vitamin D3-enriched tomatoes offer numerous advantages over traditional vitamin D supplements. They provide a sustainable, plant-based source of vitamin D3, catering to vegans, vegetarians, and individuals with dietary restrictions or limited sun exposure. Unlike vitamin D3 derived from animal sources, our tomatoes are free from the risk of chemical contamination, making them a safer and more natural alternative. Furthermore, incorporating vitamin D3 into a widely consumed food product enhances consumer acceptance and adherence to recommended dietary intakes. The market potential for our innovations is immense. By capturing a significant share of the $18 billion US wholesale tomato market, our vitamin D3-enriched tomatoes can appeal to health-conscious consumers and address the needs of populations at risk of vitamin D deficiency. Additionally, our enhanced CRISPR-Cas technologies offer transformative possibilities across various agricultural applications, positioning GFLAS for sustained growth and profitability. We are now seeking investment to accelerate our expansion and capitalize on the lucrative opportunities within the US market and beyond. Our financial projections indicate substantial growth, with a target of achieving 30% market share within four years. The infusion of capital will support scaling up production, enhancing quality control, and expanding distribution and marketing efforts. GFLAS Life Sciences invites private equity funds and strategic investors to join us in this groundbreaking venture. With our cutting-edge technologies, strong partnerships, and clear market potential, GFLAS is uniquely positioned to deliver substantial returns on investment while making a profound positive impact on global health and sustainability. We look forward to discussing this exciting investment opportunity further and exploring how we can work together to bring our revolutionary products to market.
  • Bionetix Therapeutics — Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.
Show all investments...

Kingo Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Kingo Investment Partners is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Series A, Series C, Series B
  • Geography: South Korea

Investor stats

  • Total investments: 29
  • Round size: Series A $834k–$9.4M; Series B $5.1M–$20M; Series C $3.2M–$45M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • IMBiologics — IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules.
  • Turing — Reinvent Education with Technology
  • Colosseum — Colosseum is a logistics company that provides e-commerce logistics services to various locations.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Aju IB Investment
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services.Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support.Aju IB Investment was founded in September 1974 and is basedin Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 106
  • Lead/follow: no public data

Portfolio highlights

  • Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
  • Healing Paper — Healing Paper is a mobile healthcare and information technology company.
  • Kovis Technology — Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
Show all investments...

BSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups, 6 in the past 12 months

BSK Investment is a private equity investment company that invests in unlisted companies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 52
  • Round size: Series A $2.1M–$57M; Series B $5M–$26M; Series C $15M–$24M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Bunker Kids — Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.
  • Motif Drive — Motif Drive's platform monitors multiple vehicle and environmental parameters, applies algorithms to ensure optimal performance under varying conditions, and supports adaptive adjustments and diagnostics, enabling fleet operators and drivers to manage urban driving challenges effectively while maintaining reliability and safety on the road.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
Show all investments...

Devsisters Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Venture Capital firm in Korea. We are interested in early-stage investment in gaming, healthcare/biotech, IT services and high technology companies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Gaming
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 109
  • Round size: Seed $441k–$3.5M; Series A $1.7M–$8.7M; Venture - Series Unknown $7.7M–$11M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — raised $23M in 2023

Portfolio highlights

  • Deeply — Deeply provides AI-powered sound analysis solutions for real-time monitoring across manufacturing, industrial safety, and security environments.
  • Red Brick House — Red Brick House is a specialized South Korean indie game publisher dedicated to discovering, supporting, and publishing innovative independent games, helping talented developers bring creative and engaging gaming experiences to players across domestic and global markets.
  • AWESOME Entertainment — AWESOME Entertainment is a media and digital content company that provides YouTube content production, influencer and MCN management, advertising and branded content creation, and media commerce services. The comapny supports brands with campaign planning, viral video production, and distribution across multiple social platforms, while alsooffering production outsourcing and partnership services to maximize audience reach and engagement.
Show all investments...

Medytox Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 23
  • Round size: Seed $3M–$3.4M; Series A $3.4M–$15M; Series B $4k–$44M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Nex Eye — Nex Eye is an innovative biotechnology firm that offers revolutionary immunotherapy solutions for individuals battling cancer. The company addresses the fundamental reasons behind the failure of immunotherapy, which are influenced by the biology of cancer itself. Utilizing its ON-SMRT® platform based on actual patient data and resistant cancermodels, Nex Eye identifies new immune-evasion targets such as ONCOKINE®. By transforming the approach to tackling immune resistance, the firm is pioneering a new era in cancer therapy by revitalizing the capabilities of the immune system.
  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • Inventera Pharmaceuticals — Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Show all investments...

Coolidge Corner Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Coolidge Corner Investment (CCVC) provides Seed and Seed+ funding to the most innovative tech startup companies in Korea. They proudly provide their portfolio companies a customized support in professional incubating, growth hacking, strategy, network and more.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Belgium

Investor stats

  • Total investments: 116
  • Round size: Seed $260k–$1.2M; Series A $891k–$5M; Series B $7.2M–$14M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $8.9M in 2017

Portfolio highlights

  • Frefins — Frefins is a specialized Rental Transformation (RX) company that generates value by connecting businesses, financial institutions, and consumers.
  • NexThera — Nexcera provides innovative and sustainable medical solutions.
  • Plantner — PLANTNER develops environmentally friendly polymers that utilizes the controlled-release characteristics of alginate, a polymer derived from seaweed, along with natural controlled-release fertilizers to substitute current chemical products. Concurrently, the company is engaged in research and development as well as local field trials in Korea andVietnam. These innovations are directly aimed at promoting low-input sustainable agriculture. The organization is committed to tackling the unsustainable practices prevalent in conventional agriculture through the use of slow-release fertilizers, aspiring to foster eco-friendly advancements rooted in natural materials, beginning with agriculture, which is the cornerstone of the industry. In traditional agricultural settings, the significant loss of chemical fertilizers has resulted in nutrient depletion, leading to soil degradation issues such as acidification. This reduction in soil productivity compels farmers to resort to even greater quantities of chemicals to enhance yields, thereby perpetuating a detrimental cycle of increasing overuse. As a response, coated slow-release fertilizers have been introduced; however, their synthetic polymer coatings have contributed to the buildup of microplastics in the soil, harming the habitats of beneficial microorganisms and generating additional environmental challenges. To mitigate these concerns, ongoing research and development efforts are focused on substituting the conventional coating materials of slow-release fertilizers which are responsible for environmental issues like residual microplastics with alginate, a biodegradable polymer sourced from seaweed.
Show all investments...

Daekyo Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

Daekyo Investment is a venture capital firm specialized in development of venture industry.

Show more...

Investment focus

  • Industry: Software, Mobile Apps, Education
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Hong Kong

Investor stats

  • Total investments: 76
  • Round size: Seed $589k–$13M; Series A $1.8M–$15M; Series B $3.3M–$17M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Switchwon — Switchwon provides currency exchange services.
  • Inserasolution — Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems.
  • S-Innovations — S-Innovations is a robotics software company that develops SynK, a cyber-physical AI operating system for robot deployment, integration, and recovery across different robot brands and industrial facilities. The company provides automation software that enables faster robot setup, system connectivity, and operational management for sectors usingautonomous mobile robots
Show all investments...

HG Initiative
VC Fund · Seongdong, Kyonggi-do, South Korea · 2 investments in South Korea Life Science startups

HGI runs an impact-driven business, seeking to address diverse social issues through sustainable innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 50
  • Round size: Seed $360k–$7.7M; Series A $1.1M–$11M; Series B $3.8M–$13M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Lumora — Lumora is an Independent Power Producer (IPP) specializing in transforming idle land into renewable energy assets by developing, owning, and operating sustainable power generation projects that maximize land value while supporting clean energy production.
  • Zari Company — Jari Company Co., Ltd.utilizes a mobile platform to computerize and process the entire process of real estate lease contract management, including issuing overdue bills, confirming monthly rent payments, and linking vacancies
  • Dolbom-ui-sin — Caregiver is a specialized platform operator that provides hospitals with advanced nursing solutions, streamlining patient care coordination, enhancing clinical workflows, and supporting specialized nursing practices through intelligent tools and integrated digital systems.
Show all investments...

SJ Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

SJ Investment Partners is a venture capital firm that invests in the IT and biotechnology industries.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Hong Kong

Investor stats

  • Total investments: 78
  • Round size: Seed $547k–$2.7M; Series A $1.6M–$12M; Series B $4.5M–$27M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • DevD — DevD is a startup that provides 1:1 customized content and recommendation services based on self-developed lifestyle AI algorithms.
  • Dnotitia — VDPU is a PCIe card that offloads vector index building and search from your CPUs and GPUs. It works with the vector database you already run.
  • Eleven O'Clock — Eleven O'Clock is a space management platform that offers non-face-to-face cleaning of accommodation facilities. The company's platform Keeper innovates space operation and management as the new standard for space management. The efficiency and quality of space management are improved according to the systematic manual of the Keeperplatform. The platform records and communicates every process as data, from management manuals to space status checks.
Show all investments...

Clarevoyant Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups

At Clairvoyant Ventures, we believe the most transformative innovations emerge from bold, unconventional ideas. As a venture capital firm specializing in Deep Tech, we invest in disruptive technologies that push the boundaries of science and engineering, redefining industries and shaping the future.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: South Korea

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GenKOre — GenKOre operates as a biotech company, specializing in genetic scissors.
  • Dotter — Dotter is a manufacturing company that designs and produces biodegradable optical coherence tomography devices to diagnose and treat cardiovascular diseases. The company also develops next-generation OCT equipment, an optical imaging device that can create a synergy effect when inserting stents.
Show all investments...

DSC Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in South Korea Life Science startups, 14 in the past 12 months

DSC Investments invests in early stage and growth companies in the field of corporate identify and focus, IT, software, biotechnology, machinery, and future high-growth areas such as environment and resources.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Israel

Investor stats

  • Total investments: 270
  • Round size: Seed $441k–$9.7M; Series A $1.7M–$17M; Series B $4.8M–$60M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • OQT — OQT is focusing on developing QPUs utilizing neutral atoms.
  • FuriosaAI — FuriosaAI develops system semiconductors optimized for AI, enabling efficient processing of large amounts of data in a short period of time.
  • NanoForge AI — Nanoforge AI merges AI-driven material design with robotics automation to cut material development time from years to weeks
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Neoflux
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Neoflux is a venture capital firm based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Apps, Software, Medical
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, United States

Investor stats

  • Total investments: 12
  • Round size: Series A $1.9M–$8.4M; Series B $4.5M–$56M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BeMyCar — BeMyCar offers car rental services.
  • Thingsflow — Thingsflow is a chatbot that engages in the development and operation of the character chatbot brand Hellobot.
  • 1st Biotherapeutics — At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need.
Show all investments...

Company K Partners
VC Fund · Ilsangu, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Company K Partners Limited is a principal investment firm specializing in investments in culture content, electronic components, computer, machinery, broadcasting, arts, sports, and leisure industries. The firm primarily invests in South Korea with a focus in Seoul, Gyeongnam, and Gyeonggi. Company K Partners Limited was established in 2006 and isbased in Gyeonggi-do, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Gibraltar

Investor stats

  • Total investments: 147
  • Lead/follow: no public data

Portfolio highlights

  • Qunova Computing, Inc. — Quantum computing based computing innovations for new materials and drug discovery, and advanced technology solution consulting services.
  • HydroXpand — HydroXpand is an innovative developer and manufacturer specializing in the design and production of anion exchange membrane (AEM) electrolysis stacks, which are key components in the efficient and sustainable production of hydrogen through water electrolysis.
  • Illimis Therapeutics — We translate cutting-edge science into innovative medicine
Show all investments...

JNPMEDI Partners
VC Fund · Incheon, Inch'on-jikhalsi, South Korea · 1 investments in South Korea Life Science startups

JNPMEDI Partners links investors and life sciences companies looking for funding, giving investors clear performance reports and opportunities for companies to obtain capital.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed
  • Geography: South Korea

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Kim Cell & Gene — Kimcell & Gene is creating antibody treatments that target resistance.
Show all investments...

Yuanta Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

A star of private equity market grow up your companies and ascend your potential.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, E-Commerce
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, Taiwan, Vietnam

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • MediMabBio — Creating therapeutic opportunities for the most serious diseases.
  • Selta Square — Selta Square is an AI-based drug monitoring company that provides full-cycle drug monitoring solutions using artificial intelligence technology.
  • Pin Therapeutics — Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA.* Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assaycascade for molecular glue degrader screening* Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)
Show all investments...

Mirae Asset Capital
VC Fund · Mumbai, Maharashtra, India · 1 investments in South Korea Life Science startups

Mirae Asset Capital Market is a leading global investment banking, securities and institutional business firm that provides a wide range of financial services to a substantial and diversified client base.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 152
  • Round size: Seed $817k–$18M; Series A $3.1M–$47M; Series B $8.4M–$105M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • TraceWeave — TraceWeave develops runtime intelligence and world-model technology for software-defined vehicles, machines, and interactive systems.
  • Precision Neuroscience — Restoring freedom through brain-computer interfaces
Show all investments...

Stick Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 1 investments in South Korea Life Science startups

Stick Ventures is a venture capital firm based in South Korea that prefers to invest in seed-stage, early-stage, and later-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Pharmaceutical
  • Stage:Series B, Series A
  • Geography: South Korea

Investor stats

  • Total investments: 38
  • Lead/follow: no public data

Portfolio highlights

  • Robros — Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life.
  • Ettifos — Ettifos provides flexible, reliable, and innovative V2X solutions to enable communication between all stakeholders on the road.
  • Imagoworks — Imagoworks Inc. offers a Web-based Dental CAD solution using AI, streamlining the digital workflow for dental professionals. Together with world-class technology, we are setting new standards for digital dentistry in the global market. Our mission is to <Making the future of digital medicine for everyone>.While we have accumulatedtechnological expertise in the medical field for over 10 years, specializing in AI-based automation, 3D geometric modeling and mesh processing, and software as a service (SaaS), we now turn our focus to commercializing our innovative technologies and transforming the field of digital dentistry. By cooperating with and licensing to leading global dental companies, we are seeing great success as we find ourselves in the industry spotlight.Imagoworks currently offers Dentbird Crown which automatically generates optimal crown designs with a single click and without any software installation required. As we continue to expand our services, Imagoworks aims to be recognized as a chairside design solution for dentists worldwide.
Show all investments...

Kolon Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Kolon Investment, Inc. is a venture capital and private equity firm specializing in buyouts, mezzanine, corporate restructuring, growth capital, and turnaround investment. It prefers to invest in electronic components, petroleum, energy, computer, and telecommunications equipment. The firm primarily invests in South Korea with a focus in Seoul,Gyeonggi, Incheon, and Gyeongbuk. Kolon Investment, Inc. was established in 2000 and is based in Seoul, South Korea.Source: Businessweek

Show more...

Investment focus

  • Industry: Biotechnology, Software, Pharmaceutical
  • Stage:Series A, Series B
  • Geography: South Korea, Indonesia, United States

Investor stats

  • Total investments: 95
  • Lead/follow: no public data

Portfolio highlights

  • Boosterz — Boosterz is a company that supports the 5Ps of marketing at all stages, from product planning and launch to growth.
  • ActionFit — ActionFit is a video game company with expertise in developing and publishing video games for the mobile platform.
  • SCBIO — SCBIO is a pharmaceutical company that makes drugs with specialized technologies in immuno-oncology. The company discovers and develops novel therapeutics for future medicine.
Show all investments...

G.N. Tech Venture
VC Fund · 1 investments in South Korea Life Science startups

G.N. Tech Venture is a corporate investment company that invests in electronic components.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • MIRI.DIH — MIRI.DIH is a technology-intensive e-business company.
  • Panmnesia — Innovate AI Infrastructure with Panmnesia's Link Solution. Empowering true composability in modern AI infrastructure.
  • Meissa — Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling.
Show all investments...

KB Securities
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 11 in the past 12 months

KB Securities is a Financial Services company.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 162
  • Round size: Series A $2.4M–$11M; Series B $4.7M–$25M; Venture - Series Unknown $1.5M–$35M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Klleon — Revolutionizing AI-Human Interactions with Real-Time Digital AvatarsEstablished in 2019, Klleon pioneers a fresh dimension in AI-human relations through its real-time digital avatar video chat. Recognized by industry giants like NVIDIA, AWS, and Microsoft, Klleon's unique technologies facilitate emotionally resonant AI digital avatarinteractions. Features include rapid-response digital human animations and optimized GPT processing, ensuring efficiency in both time and cost. By creating lifelike digital avatars from just a facial snapshot and 30 seconds of voice, Klleon transcends physical, temporal, spatial, and linguistic boundaries. With Klleon, your digital twin can converse globally, anytime, in any language.
  • Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
  • Woori Technology — We, Woori Technology, are trying our best to satisfy customers with continuous R&D and innovation.
Show all investments...

QUAD Investment Management
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Established in 2009, QUAD is an independent investment manager overseeing approximately US$1.0 billion in equity assets (as of June 2019). Our clients range from institutional clients such as pension funds, endowments and family offices to individual parents and their children. All investment managers and key management being equity partners of thefirm, QUAD members are significant investors in the company, which we believe aligns our goals with the interests of our clients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 21
  • Round size: Series A $847k–$23M; Series B $4M–$80M; Series C $15M–$75M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • HoneyNaps — Connected Family through Digital Healthcare.Beginning in 2015, HoneyNaps began to develop the element technology for monitoring Bio-signal and completed the platform launch. In order to derive full-cycle bio-signal management & the disease prediction model.
  • NeoCannBio — NeoCannBio provides natural product processing facilities for generating new medications derived from natural goods and built a cannabinoid library of hemp, and medical cannabis.
  • KaliVir Immunotherapeutics — multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. LEARN MORE NEWS AND EVENTSAugust 19, 2026 - KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing READ MORE November 19, 2025 - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Meritz Securities
VC Fund · 1 investments in South Korea Life Science startups

Securities, Investment, Finance, Trading company

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Pharmaceutical
  • Stage:Series C, Series A, Series B
  • Geography: South Korea, China

Investor stats

  • Total investments: 12
  • Round size: Series A $4.7M–$8.2M; Series B $16M–$22M; Series C $18M–$45M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • LDCarbon Co. — LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future.
  • Lanvin Group — Lanvin group is a fashion industry that oversees the labels lanvin, caruso, wolford, sergio rossi, and st. John knits. It is offering this assistance along with in-depth information about and connection to the fashion markets.
Show all investments...

Future Science and Technology Holdings
VC Fund · Daejeon, Taejon-jikhalsi, South Korea · 1 investments in South Korea Life Science startups

Future Science and Technology Holdings is an investment company that specializes in technology-based services.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $231k–$1.7M; Series A $2.2M–$6.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Apollon — Needle Gone, Data On
  • Protier Biotech — PROTIER Biotech is a company leading the development of therapeutics through innovative biotechnology .
  • ArcGen Bioscience — Embark on a Voyage in Immuno-Oncology
Show all investments...

Stonebridge Ventures
VC Fund · Thika, Central, Kenya · 1 investments in South Korea Life Science startups

Stonebridge Ventures was founded in 2008

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 36
  • Round size: Seed $1M–$2.7M; Series A $1.3M–$17M; Series B $3.5M–$15M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Narnia Labs — Narnia Labs is the developer of artificial intelligence-based design software designed to provide domain-based three-dimensional synthetic data. The company's software provides design creation, evaluation, optimization, and recommendation services, enabling clients from engineering and industrial design fields to develop performance bycollaborating with AI, from manufacturing to architecture, medicine, and the metaverse.
  • Labrador Labs — LABRADOR LABS began as an academic research collaboration initiative to develop an automated analytic method for detecting both known and new vulnerabilities.
Show all investments...

Cytogen
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in2010 and is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series A, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Wellmarker Bio — Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer.
  • TSD Life Sciences — TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.
Show all investments...

Time Folio Asset Management
VC Fund · 1 investments in South Korea Life Science startups

Time Folio Asset Management

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 16
  • Round size: Series A $5M–$26M; Series B $13M–$28M; Series C $12M–$33M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Monday OFF — MondayOFF is a mobile games developer and publisher specialized in Hypercasual games. With creativity and constantly evolving methods, we aim to launch your game to the top of the charts and build a worldwide audience to enjoy your games.
  • IVIM Technology — Global No.1 solution provider of IntraVital Microscopy
  • Point2 Technology — We Develop Innovative, Ultra-Low Power Connectivity SoCs Point2 Technology cloud-optimized range of high-speed SoCs and reference design platforms accelerate deployment of next generation data centers and 5G infrastructure.
Show all investments...

P&I Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 1 investments in South Korea Life Science startups

P&I Investment is a venture capital firm based in South Korea.

Show more...

Investment focus

  • Industry: Media and Entertainment, TV, Music
  • Stage:Series A, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 5
  • Round size: Series A $8.4M–$36M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • CLUSH — Clush is an AI and cloud infrastructure company that builds enterprise software to help organizations develop, deploy, and manage AI systems. The company offers cloud-native services and products, enabling customers to build, manage, and collaborate on cloud-based applications and data. Clush provides products such as Clush Kube MLOps, AIgovernance platforms, AI agents, hybrid cloud infrastructure, and enterprise collaboration tools for industries including finance, manufacturing, and public sector organizations
  • OASYS STUDIO — ​OASYS STUDIO is a cloud-native visual effects company that integrates VFX pipeline services and production within a cloud environment. They offer scalable and efficient production solutions, fostering stable collaboration structures for clients.
  • Contents Technologies — Content Technologies is a content IP-based company builder.
Show all investments...

Kiwoom Investment
VC Fund · Youidodong, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 12 in the past 12 months

Kiwoom Investment provides financial assistance with funding for small businesses.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 114
  • Round size: Series A $1.7M–$14M; Series B $4.2M–$21M; Series C $11M–$33M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • GraphAI — GraphAI AI enables seamless integration of diverse data sources for fast and user-friendly AI-powered Business Intelligence (BI).GraphAI-A leverages neural networks to maintain a comprehensive graph view and swiftly reveals valuable insights from enterprise data, facilitating trend analysis and a 360-degree customer perspective. This is achievedthrough In-DB AI technology with an intuitive low-code interface.GraphAI-T delivers accelerated and robust BI analytics by leveraging the valuable insights obtained from GraphAI-A. It further facilitates transaction processing on business data through structured queries like SQL and Cypher.
  • RX — RX is a startup that provides an on-site analysis solution for material properties, mainly serving environment, energy, inspection, and testing needs. It also develops technology related to next-generation nuclear power plants and agentic AI, supported by national R&D activity.This company helps industries assess materials and engineeringconditions more efficiently and accurately.
  • But Beautiful — A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team's projects, meetings, and connected apps.
Show all investments...

Nice Investment Partners
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups

NICE Investment Partners is a new technology finance company whose main job is to increase corporate value by discovering and investing in new technology businesses with promising growth, providing various management support, business alliances, and strategic consulting to the invested companies.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Japan

Investor stats

  • Total investments: 58
  • Round size: Seed $437k–$1.9M; Series A $2.1M–$26M; Series B $4.8M–$16M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Pensées — Pensées is a 3D bio-printer company that develops cultured meat through 3D bioprinting technology.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
  • Motif Technologies — Motif Technologies is an AI deep tech company that develops proprietary AI models and provides optimized cloud infrastructure for AI deployment, from everyday personal use to enterprise-scale applications.
Show all investments...

Widwin Investment
VC Fund · Gangneung, Kangwon-do, South Korea · 1 investments in South Korea Life Science startups

Widwin Investment is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 16
  • Round size: Series A $4.2M–$8.4M; Series B $584k–$47M; Series C $6.3M–$46M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Rodwin — Rodwin is a transportation management company specializes in vehicle consignment transportation services.
  • SMALL MACHINES — SMALL MACHINES specializes in the production of AI-driven medical diagnostic analyzers. The company focuses on the development of Cardiac Point Of Care Testing (POCT) devices specifically designed for use in emergency rooms. Additionally, it offers Lab-on-a-Chip OEM/ODM services and is engaged in the creation of digital healthcare platforms.
  • PineTree Therapeutics — PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Show all investments...

IBK Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in South Korea Life Science startups, 12 in the past 12 months

IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 119
  • Round size: Seed $148k–$4M; Series A $1.5M–$11M; Series B $3M–$17M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • BEYLESS — BEYLESS is an embedded platform for autonomous driving.
  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • Kitronyx — Tactile Pressure Distribution System
Show all investments...

Life Science Investor funding in South Korea at a glance

Stats across 148 deals from 171 investors.

171
investors
in South Korea Life Science startups
148
deals
in South Korea Life Science startups
$4.6M
median round
in South Korea Life Science startups
23%
lead investors
lead at least one round
26%
Seed
most common funding stage
100/0
VC / Angel
share of investor count

Access all 171 investors in South Korea Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in South Korea investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 171 investors investing in South Korea Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists